Page 2 - Latest Updates on Diabetes
Covid-19 linked with higher risk of type 1 diabetes in young people: Study
Children and adolescents infected with COVID-19 show a substantially higher risk of developing type 1 diabetes (T1D), according to a study of over 1 million patients aged 18 and younger
 "Covid-19 linked with higher risk of type 1 diabetes in young people: Study")
Diabetes burden: India lost 45 years of healthy life per person in 2021
By 2040, Type 1 diabetes cases to increase by 116% in India, says Lancet study
India among top 10 countries with most cases of Type 1 diabetes: Study
The estimates were tested for accuracy against real world prevalence data from 15 countries
Govt launches diabetes drug Sitagliptin, its combinations at Rs 60 per pack
At present, over 1,600 medicines and 250 surgical devices are available in these kendras, which also sells Suvidha Sanitary pads priced at Re 1 per pad
Controlling blood sugar level can predict risk to type 1 diabetics
New research states that blood sugar level should be lower than 53 mmol/mol (7%) to avoid health complications
New diabetes drug achieves blood sugar, weight targets faster: Research
T2D is a chronic and progressive condition in which the body does not make or use insulin normally, leading to high levels of glucose in the blood
Control of blood sugar in mothers with diabetes better for infants: Study
Research led by Caroline Crowther of the University of Auckland, New Zealand, and a team, the findings were published in the journal PLOS Medicine
 "Control of blood sugar in mothers with diabetes better for infants: Study")
Pricing regulator closely watching prices of diabetes drug going off patent
Regulator looking to cap prices of Sitagliptin, Linagliptin and combinations
 "Pricing regulator closely watching prices of diabetes drug going off patent")
Zydus Life launches generic version of Sitagliptin for type 2 diabetes
Zydus Lifesciences Ltd on Friday said it has launched the generic version of sitagliptin in India under the brand names Sitaglyn and Siglyn to address type 2 diabetes.
 "Zydus Life launches generic version of Sitagliptin for type 2 diabetes")
Going off-patent, key diabetes drug likely to get 50-70% cheaper
Several drugs going off-patent in the anti-diabetes category have shaken up the market share dynamics
US doctors reconsider Pfizer's Paxlovid for lower-risk Covid patients
On Tuesday, the CDC, citing case reports and concerns that relapsed patients could spread the virus, issued its advisory that Paxlovid users should isolate for a second five days if symptoms rebound
 "US doctors reconsider Pfizer's Paxlovid for lower-risk Covid patients")
Tech firm MFine helps people monitor blood pressure, glucose on smartphones
MFine has democratised health care at home by bringing these solutions on to devices that are more ubiquitous and affordable than wearables
 "Tech firm MFine helps people monitor blood pressure, glucose on smartphones")
Long Covid-induced diabetes, depression can be treated by exercise: Study
Though no medically recognized treatment exists for Long Covid, a study suggests that exercise might break cycle of inflammation that develops diabetes and depression months after a person recovers
 "Long Covid-induced diabetes, depression can be treated by exercise: Study")
Zydus gets regulator nod to market generic diabetes drug in American
Zydus Group on Wednesday said it has received final approval from the US health regulator to market diabetes medication Dapagliflozin tablets in the American market.
 "Zydus gets regulator nod to market generic diabetes drug in American")
Pharma company Abbott ties up with health tech firms for diabetes care
Abbott on Tuesday said it has tied up with health-tech firms like BeatO, Sugar.fit, PharmEasy, GOQii, 1MG and Zyla for diabetes care
 "Pharma company Abbott ties up with health tech firms for diabetes care")
India's diabetes care market to reach $60 bn in next 10 yrs: Report
The diabetes care market in India is expected to reach about $60 billion in the next 10 years, from approximately $17 billion in FY2021, a new report said
 "India's diabetes care market to reach $60 bn in next 10 yrs: Report")
Statsguru: Obesity to diabetes, 6 charts explain health concerns for India
Data shows that obesity is increasingly growing among both men and women
 "Statsguru: Obesity to diabetes, 6 charts explain health concerns for India")
Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US
These injections will help control high blood sugar in adult and pediatric patients with type-1 diabetes and adults with type-2
 "Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US")
IMA urges Covid vax, including booster dose if needed, for all diabetics
Noticing their vulnerabilities, IMA on Sunday demanded Covid-19 vaccination for all diabetes patients, including a third dose, if needed.
 "IMA urges Covid vax, including booster dose if needed, for all diabetics")
Post-Covid fatigue is most prevalent in diabetes patients: Study
People with Type-2 diabetes who also suffered Covid-19 are more likely to experience severe fatigue than those who did not have the infectious disease, according to a new study released on Thursday
 "Post-Covid fatigue is most prevalent in diabetes patients: Study")
